All Articles
PerspectivePortfolio
At Menlo, we believe the pace of innovation in new medicines will continue to accelerate, powered by the combination of advances in biology, advances…
Firm
We Are Hiring a Principal with Therapeutics Expertise: Building a Biotech Franchise at Menlo
Here at Menlo, we are building an investing practice focused on three of the most exciting areas of healthcare: therapeutic platforms, digital health, and…
PortfolioFunding
Our Investment in Riva Health: Building the Future of Cardiovascular Healthcare
Nearly half of U.S. adults—108 million people—have high blood pressure, which is the #1 controllable risk for both heart disease and stroke, the two…
PortfolioFunding
Doubling Down on H1: Menlo Co-Leads Series B, Eight Months After Leading Series A
H1 is a unique healthcare data SaaS company with proprietary data, compelling initial applications, and potential to expand.
Perspective
Four Big Trends in Digital Health
The pandemic’s pressures compressed trends toward digital and virtual care that might otherwise have taken years into a few months.
Portfolio
Pliant and the 5 Ps of Therapeutics Investing at Menlo
Congratulations to Bernard Coulie and the team at Pliant Therapeutics on a successful IPO!
PortfolioFunding
Investing in H1: SaaS Healthcare Analytics
How can we take a critical process and make it better? Many successful companies are built from answering this question.